Projects per year
Organization profile
Organisation profile
HEIM is part of the Oncology Research Center and consists of a fundamental research team located at the Faculty of the Brussels Health Campus and a translational research team located at the University Hospital. Fundamental Research consists of cancer research in different tumor models including Multiple Myeloma, Acute Myeloid Leukemia and B-cell lymphoma. The aim of this research is to find novel therapeutic targets within the field of epigenetics, tumor cross-talk and immune therapy. Translational Research covers different domains within Hematology, such as Cancer Biology, Stem Cell Therapy, Thrombophilia and HLA typing.
Keywords
- Cell Culture
- stem cell transplantation
- Immunology
- Therapy
- Oncology
- Immuno-Morphology
- Multiple Myeloma
- mesenchymal stem cells
- Diagnosis
- Molecular Biology
- Hematology
- Lymphoma
- cancer
Fingerprint
Dive into the research topics where Hematology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Marleen Bakkus
- UZBrussel
- Vrije Universiteit Brussel
- Clinical Biology - UZB Researcher
- Hematology
Person: Researcher
-
Veerle Beckers
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Hematology - UZB Physician
Person: Researcher, Physician
-
Ann De Becker
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Faculty of Medicine and Pharmacy
- Hematology - UZB Physician
Person: Researcher, PhD, Physician
-
Nathan De Beule
- UZBrussel
- Vrije Universiteit Brussel
- Clinical sciences - Academic, Undefined
- Hematology - UZB Physician
- Hematology
Person: Researcher, Physician
-
Wouter De Brouwer
- UZBrussel
- Vrije Universiteit Brussel
- Intensive Care - UZB Physician
- Hematology
- Faculty of Medicine and Pharmacy
Person: Researcher, Physician, PhD, Advanced Master's Programme
-
OZR3983: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, TU Chenggong
7/07/22 → 6/07/26
Project: Fundamental
-
OZR3740: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, DE COSTER Michiel
22/10/20 → 21/10/24
Project: Fundamental
-
FWOTM1002: Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)
1/10/20 → 30/09/23
Project: Fundamental
-
SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Vanderkerken, K., Thielemans, K., Vanderkerken, K. & Breckpot, K.
1/11/17 → 31/10/24
Project: Fundamental
Research output
-
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable – a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Drozd-Sokolowska, J., Gras, L., Zinger, N., Al Zahrani, M., Passweg, J., Byrne, J., Ho, A., Huang, X., Kröger, N., Mayer, J., Russo, D., De Becker, A., Tbakhi, A., Stamatoullas, A., Valerius, T., Hayden, P., McLornan, D. P., Onida, F., Scheid, C., Robin, M. & 1 others, , Feb 2023, In: Bone Marrow Transplantation. 58, 2, p. 222-225 4 p.Research output: Contribution to journal › Article › peer-review
-
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the Chronic Malignancies Working Party of the EBMT
Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT), Jan 2023, In: American Journal of Hematology. 98, 1, p. 112-121 10 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Genotype-phenotype correlation in Belgian patients with inherited Protein C deficiency
Bouteille, S. P., Stouffs, K., Jochmans, K. & Orlando, C., 2023, In: Belgian Journal of Hematology. suppl 1Research output: Contribution to journal › Meeting abstract (Journal)
-
Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review
van Dijk, M. J., van Oirschot, B. A., Stam-Slob, M. C., Waanders, E., van der Zwaag, B., van Beers, E. J., Jans, J. J. M., van der Linden, P. W., Torregrosa Diaz, J. M., Gardie, B., Girodon, F., Schots, R., Thielen, N. & van Wijk, R., Jan 2023, In: British Journal of Haematology. 200, 2, p. 249-255 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
HTLV-1 associated adult T-cell leukemia/lymphoma, chronic phase: an uncommon case in Belgium.
Goes, S., Demeester, S., Depreter, B., Beckers, V. & Linskens, E., 3 Feb 2023.Research output: Unpublished contribution to conference › Poster
Activities
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Internship of 1 month in collaborating lab (Laboratory for Monitoring Innovative Therapies Department of Biological Hematology CHRU de Montpellier, Hôpital St Eloi, Montpellier, France)
Catharina Muylaert (Visitor)
4 Jan 2023 → 6 Feb 2023Activity: Other › Research and Teaching at External Organisation
-
EHA
Barbara Depreter (Participant)
8 Jun 2023 → 11 Jun 2023Activity: Participating in or organising an event › Participation in workshop, seminar
-
FAKB Symposium "Oncologische uitdagingen in het klinisch laboratorium"
Robbe Heestermans (Chair)
22 Mar 2023Activity: Participating in or organising an event › Participating in or organizing a public lecture/debate
-
Characterization of the evolving mutational landscape in multiple myeloma during disease progression using blood-derived cell free DNA: an explorative study
Robbe Heestermans (Speaker), Wouter De Brouwer (Contributor), Ken Maes (Contributor), Isabelle Vande Broek (Contributor), Freya Vaeyens (Contributor), Catharina Olsen (Contributor), Toon Janssen (Contributor), Ann De Becker (Contributor), Marleen Bakkus (Contributor), Henri Schots (Contributor) & Ivan Van Riet (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
Datasets
-
Beyond medicines’ barriers: exploring the true cost of multiple myeloma
Choon-Quinones, M. (Creator), Zelei, T. (Creator), Barnett, M. (Creator), Keown, P. (Creator), Durie, B. (Creator), Kaló, Z. (Creator), Almási, T. (Creator), Harousseau, J. (Creator) & Hose, D. (Creator), figshare.ars, 2022
DOI: 10.6084/m9.figshare.21581093
Dataset